Institutional Clinical trials vigilance: situation at University Hospital of Montpellier

被引：0
|
作者：
Robin, P. [1 ]
Taconnet, G. [1 ]
Hillaire-Buys, D. [1 ]
Launay, G. [1 ]
Delonca, C. [1 ]
机构：
[1] CHU Montpellier, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [31] National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital
    Chia-Chi Lin
    Chih-Hsin Yang
    Ann-Lii Cheng
    Wing-Kai Chan
    Hong-Nerng Ho
    Drug information journal : DIJ / Drug Information Association, 2009, 43 : 361 - 363
  • [32] IMPACT OF CLINICAL-TRIALS ON THE ADOPTION OF NEW DRUGS WITHIN A UNIVERSITY HOSPITAL
    DENIG, P
    HAAIJER-RUSKAMP, FM
    WESSELING, H
    VERSLUIS, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (04) : 325 - 328
  • [33] National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital
    Lin, Chia-Chi
    Yang, Chih-Hsin
    Cheng, Ann-Lii
    Chan, Wing-Kai
    Ho, Hong-Nerng
    DRUG INFORMATION JOURNAL, 2009, 43 (03): : 361 - 363
  • [34] Biphasic Temporal Relationship between Cancers and Systemic Sclerosis: A Clinical Series from Montpellier University Hospital and Review of the Literature
    Partouche, Leo
    Goulabchand, Radjiv
    Maria, Alexandre Thibault Jacques
    Riviere, Sophie
    Jorgensen, Christian
    Rigau, Valerie
    Bourgier, Celine
    Bessis, Didier
    Le Quellec, Alain
    Quere, Isabelle
    Morel, Jacques
    Guilpain, Philippe
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [35] Use of linezolid at the Lapeyronie-Arnaud de Villeneuve university hospital of Montpellier
    Steve-Dumont, M.
    Vincent, L. -A.
    Villiet, M.
    Jalabert, A.
    Hansel-Esteller, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 440 - 440
  • [36] Overview of literature monitoring practice of clinical trials vigilance units in French institutional sponsors - A study from the REVISE working group
    Prioul, Astrid
    Fournier, Dorine
    Lefeuvre, Cecile
    Duranton, Sophie
    Olivier, Pascale
    Blanc, Emeline
    Peyro-Saint-Paul, Laure
    Ruault, Sophie
    Jamet, Aurelie
    Mouchel, Catherine
    THERAPIE, 2023, 78 (06): : 659 - 666
  • [37] Academic clinical trials vigilance activity in six university hospitals in western France: 5-year activity report
    Mouchel, C.
    Boivin, H.
    Carlhant-Kowalsky, D.
    Chiffoleau, A.
    Duranton, S.
    Jamet, A.
    Jobert, A.
    Morvan, F.
    Pinier, M.
    Bellissant, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 20 - 20
  • [38] The ethics, vigilance and rationale for conducting clinical trials during pregnancy
    Hoet, JJ
    EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 175 - 180
  • [39] Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital
    Perrier, Quentin
    Minoves, Melanie
    Cerana, Sophie
    Reymond, Fabienne
    Ducki, Camille
    Decaens, Thomas
    Lehmann, Audrey
    Bedouch, Pierrick
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (06) : 520 - 525
  • [40] The contemporary situation for the conduct of clinical trials in Asia
    Fenn C.G.
    Wong E.
    Zambrano D.
    International Journal of Pharmaceutical Medicine, 2001, 15 (4) : 169 - 173
12345